MOTS-c 10 mg
$42.00
British Dragon MOTS-c 10 mg – Mitochondrial-Derived Peptide
British Dragon MOTS-c 10 mg is a mitochondrial-derived peptide encoded by the mitochondrial genome, distinct from nuclear-encoded peptides. Each 2 mL vial contains 10 mg of lyophilized MOTS-c, ready for reconstitution for research applications involving metabolic regulation, insulin sensitivity, and cellular energy homeostasis.
MOTS-c has gained significant attention in metabolic research due to its ability to influence AMPK activation and improve insulin sensitivity in animal models. Unlike traditional growth hormone peptides or GHRPs, MOTS-c operates through mitochondrial signaling pathways. For researchers studying metabolic function, this peptide represents a unique tool. Explore similar research compounds like Ipamorelin 5 mg or GHK-CU 50 mg.
What Makes British Dragon MOTS-c Unique?
MOTS-c is one of the few known peptides encoded by mitochondrial DNA (mtDNA) rather than nuclear DNA. It translocates to the nucleus under metabolic stress conditions, influencing gene expression related to metabolism and inflammation. This distinct origin and mechanism sets it apart from synthetic peptides or hormone analogs.
For performance-focused research, MOTS-c is often studied in the context of metabolic adaptation and energy expenditure. The 10 mg dosage provides sufficient material for extended protocols investigating chronic metabolic interventions. Researchers may also combine MOTS-c with other metabolic research tools to evaluate comprehensive pathway interactions.
Benefits of British Dragon MOTS-c for Research
- ✔ Mitochondrial-encoded peptide for unique signaling research
- ✔ AMPK pathway activator in animal models
- ✔ 10 mg lyophilized powder for robust research protocols
- ✔ Suitable for subcutaneous administration research
- ✔ Relevant for metabolic and insulin sensitivity studies
British Dragon MOTS-c 10 mg is intended for laboratory research only. Not for human consumption or clinical use.
External research on MOTS-c's mechanisms can be explored via PubMed for peer-reviewed studies.